Moderna, Inc. ( MRNA) - Key Metrics
MRNA Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.37 | -$1.97 | -$1.33 | -$1.42 |
| 2026Q1 | $0.98 | -$3.40 | -$1.59 | -$1.75 |
| 2025Q4 | $1.73 | -$2.11 | $2.43 | $2.33 |
| 2025Q3 | $2.61 | -$0.51 | -$2.17 | -$2.26 |
| 2025Q2 | $0.37 | -$2.13 | -$2.37 | -$2.38 |
MRNA Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -8.93 |
| 2026Q1 | 0% | -3.74 |
| 2025Q4 | 0% | -3.49 |
| 2025Q3 | 0% | -12.66 |
| 2025Q2 | 0% | -3.24 |
MRNA
Price: $146.69
52 week price:
Payout Ratio Range:
Earnings Per Share: -7.98 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 3.3 million
Market Capitalization: 57.8 billion